Sri Sai Nikitha Pharma Private Limited

Sri Sai Nikitha Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24232TG2007PTC054116 Incorporated 24 May 2007 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2020
-
Latest filing
EBITDA · FY 2020
*****
▲ 99.07% YoY
Net profit · FY 2020
*****
▲ 98.16% YoY
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Open charges
None
Satisfied ₹80 Lakh
Company age
19 yrs
Est. 2007
Last financials
Mar 2020
Balance sheet date

About Sri Sai Nikitha Pharma Private Limited

Data last updated: 13 February 2026

Sri Sai Nikitha Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 24 May 2007, the company has been in operation for over 19 years.

Registered with ROC Hyderabad under CIN U24232TG2007PTC054116.

Capital: an authorised share capital of ₹25 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Kalpana Beeravolu and Ramachandra Reddy Beeravolu.

Last AGM: 31 December 2020. Financial statements filed for year ended 31 March 2020. Office: 8 – 3 – 318/6/5/11 Yellareddy Guda, Hyderabad, Telangana, India – 500073.

As per MCA filings, the company has satisfied charges of ₹80 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Sri Sai Nikitha Pharma Private Limited
CIN U24232TG2007PTC054116
Registration Number 054116
Incorporation Date 24 May 2007
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2020
Date of Balance Sheet 31 March 2020
Compliance Status Active Compliant
Key People
Ramachandra Reddy Beeravolu Whole-Time Director Desireddy Reddy Venkata Whole-Time Director Kalpana Beeravolu Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    8 – 3 – 318/6/5/11 Yellareddy Guda, Hyderabad, Telangana, India – 500073
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Sri Sai Nikitha Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sri Sai Nikitha Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Sri Sai Nikitha Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Sri Sai Nikitha Pharma Private Limited

Sri Sai Nikitha Pharma Private Limited has one previous CIN (Corporate Identification Number): U24232AP2007PTC054116. The current CIN is U24232TG2007PTC054116, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24232TG2007PTC054116 Current
U24232AP2007PTC054116 Previous

Auditor Details of Sri Sai Nikitha Pharma Private Limited

Sri Sai Nikitha Pharma Private Limited is audited by SURYANARAYANA REDDY & CO for the financial year 2018. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
SURYANARAYANA REDDY & CO blur-value blur-value blur-value

Board of Directors of Sri Sai Nikitha Pharma Private Limited

Sri Sai Nikitha Pharma Private Limited is currently managed by 3 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Kalpana Beeravolu
Also directs: Sri Sai Nikitha Pharma Private Limited
Director 24 May 2007 19 Years 1 Months Current
Ramachandra Reddy Beeravolu
Also directs: Sri Sai Nikitha Pharma Private Limited, Elegant Infra Homes Llp
Whole-Time Director 10 Apr 2008 18 Years 3 Months Current
Desireddy Reddy Venkata
Also directs: Connex Pharma Private Limited, Sri Sai Nikitha Pharma Private Limited
Whole-Time Director 10 Apr 2008 18 Years 3 Months Current
View all directors

Financials of Sri Sai Nikitha Pharma Private Limited FY 2020 filings available

Sri Sai Nikitha Pharma Private Limited reported revenue of ₹- (up ) for FY 2020. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
-
Profit
***** ▲ 98.16%
EBITDA
***** ▲ 99.07%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Sri Sai Nikitha Pharma Private Limited

As of FY 2018, Sri Sai Nikitha Pharma Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Sri Sai Nikitha Pharma Private Limited

Open charges
₹0
Satisfied charges
₹80 Lakh
Breakdown by lending institutions
Union Bank of India₹0.80 Cr
Latest charge details
DateLenderAmountStatus
10 Jun 2009 Union Bank of India ₹80 Lakh Satisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Sri Sai Nikitha Pharma Private Limited

View historical data on people associated with Sri Sai Nikitha Pharma Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Sri Sai Nikitha Pharma Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Sri Sai Nikitha Pharma Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Sri Sai Nikitha Pharma Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Sri Sai Nikitha Pharma Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Sri Sai Nikitha Pharma Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Sri Sai Nikitha Pharma Private Limited

MSME Payment Delays by Sri Sai Nikitha Pharma Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Sri Sai Nikitha Pharma Private Limited

Subsidiaries & Group Companies of Sri Sai Nikitha Pharma Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Sri Sai Nikitha Pharma Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Sri Sai Nikitha Pharma Private Limited

MCA Filings & Documents of Sri Sai Nikitha Pharma Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Sri Sai Nikitha Pharma Private Limited

Activity
31 Dec 2020
Sri Sai Nikitha Pharma Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Activity
31 Mar 2020
Sri Sai Nikitha Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.
Charges
09 Jul 2019
A charge registered on 10 Jun 2009 via Charge ID 10164978 with Union Bank Of India was fully satisfied on 09 Jul 2019.
Charges
10 Jun 2009
A charge with Union Bank Of India amounted to Rs. 80.00 Lakh with Charge ID 10164978 was registered on 10 Jun 2009.
Directors
10 Apr 2008
Ramachandra Reddy Beeravolu was appointed as a Whole-time director on 10 Apr 2008 & has been associated with this company since 18 years 3 months.
Directors
10 Apr 2008
Desireddy Reddy Venkata was appointed as a Whole-time director on 10 Apr 2008 & has been associated with this company since 18 years 3 months.

Frequently Asked Questions about Sri Sai Nikitha Pharma Private Limited

Sri Sai Nikitha Pharma Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 24 May 2007 (19+ years old) and is registered under CIN U24232TG2007PTC054116.

The current directors of Sri Sai Nikitha Pharma Private Limited are:

The primary industry of Sri Sai Nikitha Pharma Private Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.

Sri Sai Nikitha Pharma Private Limited can be reached at the registered office: 8 – 3 – 3186511 Yellareddy Guda, Hyderabad, Telangana, India – 500073.

The authorised capital is ₹25 Lakh, and the paid-up capital is ₹2 Lakh.

The company has its registered office at 8 – 3 – 3186511 Yellareddy Guda, Hyderabad, Telangana, India – 500073.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available